Frank S Hodi
ECOG-ACRIN Cancer Research Group
3
3
1
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rodabe N Amaria
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey
Shared therapeutic areas:
Worked with same sponsors:
Vincent Chung
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
David S Hong
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jun Guo, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
James C Yang, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Antoni Ribas, MD
University of California, Los Angeles
Shared therapeutic areas:
Worked with same sponsors:
Wenyin Shi, MD, PhD
Thomas Jefferson University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
All 3 trials loaded